BENLYSTA 200 mg, solution for injection in a pre-filled pen 4 pens of 1 ml
Active ingredients: BÉLIMUMAB
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection4 pens of 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BENLYSTA 200 mg, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 4 stylos composés de 4 seringues préremplies en verre de 1 ml avec aiguilles sécurisées
- Marketing authorisation holder
- GLAXOSMITHKLINE (IRELAND)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Nov 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
60205159CIP73012690CIP133400930126905Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉLIMUMABsolution | 200 mg · un stylo prérempli de 1 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.